0001209191-19-025198.txt : 20190417 0001209191-19-025198.hdr.sgml : 20190417 20190417212820 ACCESSION NUMBER: 0001209191-19-025198 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190415 FILED AS OF DATE: 20190417 DATE AS OF CHANGE: 20190417 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CASTANEDA MARK CENTRAL INDEX KEY: 0001247157 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38594 FILM NUMBER: 19754335 MAIL ADDRESS: STREET 1: 1304B 7TH AVE N. CITY: NASHVILLE STATE: TN ZIP: 37208 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tilray, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1920 EASTLAKE AVENUE E. CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 2064329325 MAIL ADDRESS: STREET 1: 1920 EASTLAKE AVENUE E. CITY: SEATTLE STATE: WA ZIP: 98102 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-15 0 0001731348 Tilray, Inc. TLRY 0001247157 CASTANEDA MARK 1100 MAUGHAN ROAD NANAIMO A1 V9X IJ2 BRITISH COLUMBIA, CANADA 0 1 0 0 CFO, Secretary, Treasurer Class 2 Common Stock 2019-04-15 4 M 0 10000 7.76 A 18205 D Class 2 Common Stock 2019-04-15 4 S 0 10000 51.72 D 8205 D Stock Option (Right to Buy) 7.76 2019-04-15 4 M 0 10000 0.00 D 2028-05-20 Class 2 Common Stock 10000 520000 D The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.62 to $51.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote 3 to this Form 4. The shares vest at a rate of 50% of the total shares on July 18, 2019 (the "Vesting Date"), with the remaining 50% of the total shares vesting upon the one-year anniversary of the Vesting Date, provided that the Reporting Person remains in Continuous Service (as defined in the Company's 2018 Equity Incentive Plan) until such date. /s/ Alan Hambelton, Attorney-in-fact 2019-04-17